The Brain Imaging and Neuroimaging Market size was valued at US$ 16.05 billion in 2025 and is projected to reach US$ 25.82 billion by 2033, registering a CAGR of 6.12% from 2026 to 2033. Neurological disease diagnosis, AI-assisted imaging, multimodal systems, aging populations, precision medicine, and expanding neurodiagnostic infrastructure are supporting market growth. AI-based neurological quantification, portable and decentralized neurodiagnostic platforms, and radiopharmaceutical and molecular imaging expansion are creating new opportunities for imaging manufacturers, software developers, and diagnostic providers.
Market Overview
The Brain Imaging and Neuroimaging Market is evolving as healthcare providers increasingly seek quantitative, software-enabled, and multimodal neurological imaging. The market is segmented by device into Magnetic Resonance Imaging, Positron Emission Tomography, Electroencephalography, Computed Tomography, and Others; by product type into Fixed and Portable; by application into Brain Tumors, Multiple Sclerosis, Dementia, and Others; and by end user into Hospitals, Specialty Clinics, Diagnostic Centers, and Others.
North America remains the leading regional market, accounting for approximately 34%–37% of the market in 2025, supported by advanced MRI infrastructure, neurological research, reimbursement capacity, AI integration, and demand for quantitative imaging. Asia Pacific is expected to record the fastest regional growth through 2033, supported by expanding diagnostic capacity, technology localization, private healthcare investment, and increasing adoption of advanced imaging.
Check valuable insights in the Brain Imaging and Neuroimaging Market report. You can easily get a sample PDF of the report – https://www.businessmarketinsights.com/sample/BMIPUB00039362
Key Market Trends
Dominance of Magnetic Resonance Imaging
Magnetic Resonance Imaging accounted for approximately 43%–47% market share in 2025 and is projected to grow at a 6.0%–6.6% CAGR through 2033. Superior soft-tissue visualization, neurological applications, higher-field systems, quantitative imaging, and integration with artificial intelligence support leadership.
Rapid Growth of Portable Systems
Portable products accounted for approximately 17%–21% market share in 2025 and are projected to register the fastest growth at a 7.1%–7.9% CAGR. Decentralized diagnosis, emergency neurological assessment, lower infrastructure requirements, and mobile care are driving demand, while Fixed systems retain approximately 79%–83% share.
Hospitals Lead End-User Demand
Hospitals accounted for approximately 49%–53% of the market in 2025 because they require broad modality coverage and handle more complex neurological cases, while diagnostic centers are growing rapidly with outpatient imaging demand.
AI, Quantitative Imaging, and Multimodal Workflows
AI is moving beyond image reconstruction toward automated segmentation, lesion quantification, disease monitoring, workflow prioritization, and decision support, while multimodal MRI, PET, CT, and EEG workflows broaden clinical information.
Global Market Insights
The market is being shaped by neurological disease diagnosis, AI-assisted imaging, and the shift toward integrated hardware, software, and workflow solutions. Vendors are increasingly focusing on quantitative imaging, cloud-based workflows, molecular imaging, and software subscriptions alongside scanner sales.
The ecosystem spans scanner manufacturers, radiopharmaceutical suppliers, EEG specialists, AI developers, imaging software providers, healthcare systems, and diagnostic service operators. Imaging companies are increasingly acquiring software, AI, cloud, and radiopharmaceutical capabilities, and purchasing decisions increasingly weigh total workflow economics rather than scanner specifications alone.
MRI remains the largest modality, while PET offers additional upside where molecular imaging requires metabolic or molecular characterization. Meanwhile, Asia Pacific offers the strongest expansion profile as imaging infrastructure improves across China, India, Japan, South Korea, and Southeast Asia.
Explore the Brain Imaging and Neuroimaging industry overview for additional market insights: https://www.businessmarketinsights.com/reports/brain-imaging-and-neuroimaging-market/snippet
Regional Analysis
North America
North America held approximately 34%–37% of the global market in 2025 and is projected to grow at a 5.7%–6.4% CAGR through 2033. Extensive MRI and CT installed bases, specialist neurological centers, research funding, reimbursement infrastructure, and early AI adoption support the region.
The United States accounts for approximately 82%–86% of regional demand and is projected to grow at a 5.8%–6.5% CAGR. Neurological disease diagnosis, advanced academic hospitals, high imaging utilization, pharmaceutical research, and strong vendor presence are supporting continued expansion, with Canada adding demand through hospital modernization and academic neuroscience programs.
Europe
Europe accounted for approximately 27%–30% of market share in 2025 and is expected to register a 5.4%–6.1% CAGR during 2026–2033. Germany, the United Kingdom, France, Italy, and Spain are leading markets, while Poland and certain Central and Eastern European markets show higher growth at 6.5%–7.3%.
Aging populations, public healthcare upgrades, research investment, and a focus on energy efficiency, interoperability, and data management are strengthening regional demand.
Asia Pacific
Asia Pacific represented approximately 25%–29% of the market in 2025 and is projected to record the fastest regional growth at a 7.0%–7.8% CAGR through 2033. China, Japan, India, South Korea, and Australia are leading demand centers, with China and India offering substantial capacity-expansion potential.
Private hospitals, diagnostic chains, domestic manufacturing, and government healthcare investment are broadening access to advanced imaging modalities across the region.
Rest of the World
The Rest of the World region accounted for approximately 9%–12% share in 2025 and is projected to expand at a 5.8%–6.8% CAGR through 2033. Brazil and Mexico lead Latin America through private diagnostic expansion, while Gulf countries invest in tertiary hospitals and specialized neurological care, with Saudi Arabia and the UAE growing at 6.4%–7.2%.
Market Forecast by 2033
The Brain Imaging and Neuroimaging Market is projected to increase from US$ 16.05 billion in 2025 to US$ 25.82 billion by 2033, reflecting a 6.12% CAGR during 2026–2033.
Magnetic Resonance Imaging remains the leading device, accounting for approximately 43%–47% market share in 2025, while Portable is the fastest-growing product type. Hospitals are the leading end user, North America leads by share, and Asia Pacific is the fastest-growing region.
Strategic Analysis
Companies operating in the market are focusing on integrated hardware, AI, molecular imaging, workflow software, and service capabilities. AI-enabled quantification, portable platforms, and cloud-based workflows provide opportunities to expand access and recurring software revenue, while emerging markets provide additional avenues for expansion.
Strategic priorities include integrating AI with MRI, PET, and CT platforms, expanding quantitative and longitudinal imaging software, building portable and lower-cost configurations, securing radiopharmaceutical and molecular imaging capabilities, and strengthening interoperability, cybersecurity, and training.
Market Drivers
Rising Demand for Early and Quantitative Neurological Diagnosis
Growing numbers of patients with dementia, multiple sclerosis, epilepsy, stroke, and brain tumors are increasing demand for earlier diagnosis and tracking of disease progression. MRI provides high-resolution soft-tissue imaging without ionizing radiation, PET adds metabolic and molecular data, and AI-based segmentation turns images into quantitative biomarkers.
AI Integration Is Increasing Imaging Productivity
AI is being integrated into acquisition, reconstruction, triage, segmentation, reporting, and comparison. Vendors are shifting from stand-alone algorithms to integrated solutions that connect scanners, PACS, clinical applications, and decision support, creating software and service opportunities.
Expansion of Multimodal and Molecular Neuroimaging
Structural imaging alone cannot capture certain biological features of neurological disease. MRI, PET, CT, and EEG each provide complementary anatomical, functional, metabolic, and electrical information, and partnerships continue to advance long-field-of-view and total-body PET/CT technology.
Market Opportunities
AI-Based Neurological Quantification and Decision Support
Neurological diseases often require repeated examinations and objective comparison over time. Lesion segmentation, volume quantification, and treatment-related change measurement can generate recurring revenue through subscriptions, enterprise licensing, and cloud-based centralized analysis.
Portable and Decentralized Neurodiagnostic Platforms
Portable neuroimaging and EEG equipment can address capacity constraints in emergency rooms, ICUs, ambulances, rural hospitals, specialty clinics, and mobile imaging services, particularly in developing countries where tertiary care is clustered.
Radiopharmaceutical and Molecular Imaging Expansion
Neuroscience research is moving toward biological processes and biomarkers, making PET and radiopharmaceutical availability strategically important. Vertical integration can improve access to imaging agents while supporting broader PET utilization.
Market Restraints
High Capital and Infrastructure Requirements
MRI, PET, and high-end CT systems require significant capital along with site preparation, shielding, power, cooling, service infrastructure, and trained personnel. These costs can delay purchases at smaller hospitals and diagnostic centers, so flexible financing, leasing, and scalable configurations are important.
Specialist Skills, Data Governance, and Interoperability Constraints
Neuroimaging generates extensive datasets that require radiologists, neurologists, physicists, and technologists. AI deployment adds cybersecurity, validation, and governance needs, and a lack of unified software environments can limit data flow among scanners, PACS, EHRs, and AI systems.
Competitive Landscape
The competitive environment is increasingly shaped by integrated hardware, AI, molecular imaging, workflow software, and service capabilities. Large imaging manufacturers compete with specialized EEG, neuroscience, research, and digital-health companies.
Key players profiled in the report include:
- GE HealthCare Technologies Inc.
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- FUJIFILM Holdings Corporation
- Bruker Corporation
- Medtronic plc
- Nihon Kohden Corporation
- Natus Medical Incorporated
- Compumedics Limited
Get Premium Research Report of Brain Imaging and Neuroimaging Market Size and Growth Report by 2033 at: https://www.businessmarketinsights.com/buy/BMIPUB00039362
Conclusion
The Brain Imaging and Neuroimaging Market is positioned for steady growth through 2033 as neurological disease diagnosis, AI-assisted imaging, multimodal workflows, and aging populations continue to expand. MRI and PET, portable systems, quantitative software, and cloud-based workflows provide attractive opportunities for industry participants.
North America will continue to provide a strong revenue base, while Asia Pacific is emerging as the fastest-growing region. Companies that combine integrated hardware and software, AI-enabled quantification, strong clinical partnerships, and flexible, scalable offerings are well positioned to capitalize on future market opportunities.
Related Reading / Reports
- Neurostimulation Devices Market: Analysis of neurostimulation device types, clinical applications, regional demand, and competitive developments.
- Deep Brain Stimulation Devices Market: Analysis of deep brain stimulation devices, indications, regional demand, and growth opportunities.
- Brain Implants Market: Analysis of brain implant technologies, applications, regional demand, and competitive landscape.
- Molecular Imaging Market: Analysis of molecular imaging modalities, clinical applications, regional demand, and industry opportunities.
About Us
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Contact us:
- If you have any questions about this report or would like further information, please contact us:
- Contact person: Ankit Mathur
- Email: sales@businessmarketinsights.com
- Phone: +16467917070
